首页> 外文期刊>Acta biomaterialia >Blood interactions with nano- and microfibers: Recent advances, challenges and applications in nano- and microfibrous hemostatic agents
【24h】

Blood interactions with nano- and microfibers: Recent advances, challenges and applications in nano- and microfibrous hemostatic agents

机译:与纳米和微纤维的血液相互作用:纳米和微纤维止血剂中最近的进展,挑战和应用

获取原文
获取原文并翻译 | 示例
       

摘要

Nanofibrous materials find a wide range of applications, such as vascular grafts, tissue-engineered scaffolds, or drug delivery systems. This phenomenon can be attributed to almost arbitrary biomaterial modification opportunities created by a multitude of polymers used to form nanofibers, as well as by surface functionalization methods. Among these applications, the hemostatic activity of nanofibrous materials is gaining more and more interest in biomedical research. It is therefore crucial to find both materials and nanofiber structural properties that affect organism responses. The present review critically analyzes the response of blood elements to natural and synthetic polymers, and their blends and composites. Also assessed in this review is the incorporation of pro-coagulative substances or drugs that can decrease bleeding time. The review also discusses the main animal models that were used to assess hemostatic agent safety and effectiveness.
机译:纳米纤维材料发现广泛的应用,如血管移植物,组织工程支架或药物递送系统。 这种现象可以归因于通过用于形成纳米纤维的多种聚合物,以及通过表面官能化方法产生的几乎任意的生物材料改性机会。 在这些应用中,纳米纤维材料的止血活性在生物医学研究中越来越感兴趣。 因此,找到影响生物反应的材料和纳米纤维结构性质至关重要。 本综述重点分析了血液元素对天然和合成聚合物的响应,以及它们的共混物和复合材料。 在本综述中还评估了掺入可以降低出血时间的促凝固物质或药物。 审查还讨论了用于评估止血剂安全性和有效性的主要动物模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号